MARKET

TECH

TECH

Bio-Techne
NASDAQ

Real-time Quotes | Nasdaq Last Sale

206.03
-2.84
-1.36%
After Hours: 206.14 +0.11 +0.05% 16:30 02/21 EST
OPEN
208.02
PREV CLOSE
208.87
HIGH
210.64
LOW
205.94
VOLUME
148.85K
TURNOVER
--
52 WEEK HIGH
223.29
52 WEEK LOW
178.28
MARKET CAP
7.90B
P/E (TTM)
41.53
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of TECH and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TECH stock price target is 237.88 with a high estimate of 270.00 and a low estimate of 218.00.

EPS

TECH News

More
  • Trip.com delays Q4 report
  • seekingalpha · 1d ago
  • Google, state AGs settle on outside consultants - CNBC
  • seekingalpha · 1d ago
  • NBCUniversal eyes Vudu purchase - WSJ
  • seekingalpha · 1d ago
  • Intelsat, SES bicker over C-band proceeds
  • seekingalpha · 1d ago

Industry

Biotechnology & Medical Research
+0.37%
Pharmaceuticals & Medical Research
+0.54%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About TECH

Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences reporting segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and reagents, to the biotechnology community. The Protein Sciences segment also provides an array of platforms useful in various areas of protein analysis. The Diagnostics and Genomics reporting segment provides blood chemistry and blood gas quality controls, hematology instrument controls, diagnostics immunoassays and other bulk and custom reagents for the in vitro diagnostic market.
More

Webull offers kinds of BIO-TECHNE Corp stock information, including NASDAQ:TECH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TECH stock news, and many more online research tools to help you make informed decisions.